Pfizer and Project HOPE Collaborate
  in the Fight against HIV/AIDS in Hubei
Share :  
  • Wuhan    March 29, 2006

  • Pfizer and Project HOPE today jointly announced the official launch of a collaborative HIV/AIDS healthcare training program to be conducted in partnership with the Chinese Center for Disease Control and Prevention (CDC) in Wuhan, the capital city of Hubei Province.

    In line with an agreement signed in 2005, Pfizer funded a one million yuan grant (US$125,000) to Project HOPE, an international health education and humanitarian assistance organization. This partnership program includes HIV training programs for healthcare providers at the Zhongnan Hospital in Wuhan and in the 10 highest HIV prevalence counties in Hubei Province. The program will aid over 300 healthcare providers in treating HIV/AIDS across the entire Hubei Province.

    "Partnerships like this will advance the Chinese government's priority to train more healthcare providers in the fight against HIV/AIDS," said Mr. E. Allan Gabor, Vice President of Pfizer Asia. "This new initiative will help enhance the healthcare infrastructure to better manage patients living with HIV/AIDS in China."

    "AIDS throughout China is an epidemic of great concern," said John P. Howe III, M.D., President and CEO of Project HOPE. "Project HOPE, Pfizer and the Chinese government all share a common goal–to deter the spread of this deadly virus. This long–term partnership will join the best in AIDS prevention, treatment and care."

    In recent years, China has faced increasing HIV/AIDS transmission rates from high risk individuals to the general population. A recent HIV/AIDS report revised the count to approximately 650,000 HIV/AIDS-infected individuals in China. Last March, Vice Premier Wu Yi stated in a nationwide HIV/AIDS conference, "To succeed in AIDS prevention and treatment is not only an unshakable obligation of the Chinese government but also the common responsibility of society as a whole, including business."

    To increase efforts to combat HIV/AIDS, Pfizer has also introduced the Global Health Fellows (GHF) program in China. The Global Health Fellows program is a unique approach to corporate social responsibility that pairs Pfizer employees with non-governmental organizations (NGOs) working to fight HIV/AIDS, tuberculosis, malaria, and other devastating diseases. For China, the GHF program enabled two leading Pfizer U.S. scientists, Ms. Miao-Miao Hong and Mr. Sun Dexue, to share their expertise in database management and laboratory management with Chinese medical counterparts at the Zhongnan Hospital, and other townships hospitals across the Hubei Province. These two Global Health Fellows will focus their efforts on evaluating and updating local clinical laboratory techniques.

    Also present at the ceremony was Mr. Ahmet Esen, Chairman and General Manager of Pfizer China, Ms. Paula Luff, Senior Director of Corporate Philanthropy, Pfizer Inc., Wuhan BOH officials, Wuhan University leaders and Professor Gui Xi'en, widely recognized as the foremost HIV/AIDS expert from Zhongnan Hospital.

    Pfizer is a global research-based company, discovering, developing, manufacturing and marketing leading prescription medicines for humans and animals and many of the world's best-known consumer brands. To date, Pfizer has invested more than US$500 million in China. With an unequalled product portfolio, Pfizer China remains a strong leader in the therapeutic areas of cardiovascular disease, endocrinology, neuroscience, arthritis and other inflammatory diseases, infectious disease, urology and oncology. For more information, please visit http://www.pfizer.com.cn.

    Founded in 1958, Project HOPE (Health Opportunities for People Everywhere) is dedicated to providing lasting solutions to health problems, with the mission of helping people to help themselves. Identifiable to many by the SS HOPE, the world's first peacetime hospital ship, Project HOPE now conducts land-based medical training and health education programs in 30 countries across five continents. For more information, please visit http://www.projecthope.org.

Text SizeAAA